Inflammatory pseudotumor of the liver: a case report and review of the literature by Ntinas, Achilleas et al.
CASE REPORT Open Access
Inflammatory pseudotumor of the liver: a case










Introduction: Inflammatory pseudotumor of the liver represents a fairly uncommon pathology. Although it is a
benign tumor, the correct diagnosis can be missed.
Case presentation: We report the case of a 55-year-old Caucasian man, who presented with a one-month history
of abdominal pain and weight loss. He was diagnosed with a primary liver tumor by computed tomography and
magnetic resonance imaging. Alpha-fetoprotein levels ranged within normal limits. A right posterior sectorectomy
was performed. Histopathology revealed an inflammatory pseudotumor of the liver. Our patient remains in good
condition one year later.
Conclusion: Although inflammatory pseudotumor of the liver is usually a benign process, controversy regarding its
management still exists. With this case report we review the existing literature and consider hepatectomy as a safe
treatment approach.
Introduction
Inflammatory pseudotumors (IPTs) are reactive condi-
tions that occur in many organs. They have been
reported in the lung, which is the most common site of
occurrence, central nervous system, major salivary
glands, kidney, liver, omentum, ovary, larynx, urinary
bladder, breast, pancreas, spleen, lymph nodes, skin, soft
tissues, orbit etc. [1]. The first report of an hepatic IPT
was published by Pack and Baker in 1953 [2]. This
entity has also been described as inflammatory myofi-
broblastic tumor, plasma cell granuloma, histiocytoma
and fibroxanthoma. Someren classified inflammatory
pseudotumors into three groups according to histology.
The first of these is xanthogranuloma-type pseudotu-
mors, the second is plasma cell granuloma-type pseudo-
tumors and finally there are sclerosing pseudotumors
[3]. Macroscopically, the lesion may mimic a malignancy
and may be single or multiple. Its dimensions may be
up to 25 cm. Microscopically, IPT is characterized by
spindle-shaped cells, myofibroblasts and mixed
inflammatory cells (plasma cells, lymphocytes and, spor-
adically, histiocytes).
T h el i t e r a t u r es u r v e yt od a t ei n d i c a t e s1 3 0p u b l i c a -
tions with 289 cases of hepatic IPTs [4-6]. The preva-
lence of this condition, although low, is not irrelevant.
In a retrospective analysis of 403 patients who under-
went surgery for focal liver lesions, the incidence of
IPTs was 0.7% [6]. Published data report that out of 188
patients with IPT, 106 underwent liver resection and 76
were treated conservatively, 5 out of whom subsequently
also had to undergo surgery because their initial medical
treatment failed [4]. Upon diagnosis, the proposed treat-
ment of IPTs is rather conservative, administering either
antibiotics or steroids [7]. However, occasional reports
advocated the use of more radical treatment, that is to
say, its resection [1,4].
Case presentation
We report on a 55-year-old Caucasian man, who pre-
sented with a three-day history of right upper quadrant
abdominal pain. He also complained of anorexia and
weight loss (5 kg) in one month. He had no fever or
night sweats and he presented without jaundice. Our
patient was submitted to a chest X-ray, ultrasonography
(USG) of the abdomen, triple-phase contrast computed
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(MRI) of the abdomen. As part of the metastatic work-
up he was also submitted to a chest CT, esophagogas-
troscopy and colonoscopy. A laboratory blood test for
serum albumin, serum total bilirubin, alanine amino-
transferase, aspartate aminotransferase, prothrombin
time, hepatitis B surface antigen, and antibodies to
hepatitis C, serum alpha-fetoprotein (AFP), carcinoem-
bryonic antigen and carbohydrate antigen 19-9 (CA 19-
9) were obtained. An abdominal CT and MRI showed a
well-defined heterogeneous mass situated in his right
hepatic lobe measuring 4.0 cm × 4.0 cm (Figure 1). The
lesion featured central necrosis, a hyper-dense rim and a
mild enrichment from the arterial phase in the CT, thus
conformable to malignancy. A metastatic work-up was
negative. Laboratory investigations showed normal liver
function tests, no hepatitis B or C infection, no leucocy-
tosis and normal AFP and CA 19-9 levels. The diagnosis
of primary hepatic malignant tumor and the indication
of its resection were strongly suspected by the tumor
board of our institute. A right posterior sectorectomy
was performed with the aid of intra-operative USG. The
lesion was found in Couinaud’ss e g m e n t s6a n d7 .T h e
right sub-diaphramatic space was drained for 72 hours
and intra-operative blood loss was 180 ml. The post-
operative course was uneventful. Our patient was dis-
charged on the eighth post-operative day.
The specimen of liver parenchyma that was delivered
for histopathological evaluation was 254 g in weight. It
measured 12.5 cm × 11.0 cm × 5.5 cm. A white/yellow,
relatively well-circumscribed lesion, 4.0 cm in diameter,
was identified. The removal of the tumor was complete.
Microscopic examination revealed a process with benign
characteristics, which included numerous inflammatory
cells - mature plasma cells, lymphocytes, eosinophils
and macrophages, most of them with xanthomatous
changes (Figure 2). To exclude the possibility of carci-
noma and dendritic sarcoma, monoclonal antibodies
against broad-spectrum keratin (AE1/AE3, Dako,
Glostrup, Denmark), and CD21 (Dako) were applied
through a standardized immunohistochemical method
(Nexes, Ventana, Tuscon, USA). Both antibodies had
negative reactions in the cells of the lesion (Figure 3). In
addition, many of the fibroblasts presented myofibro-
blastic phenotype, since they were positive to an anti-
body against a-smooth muscle actin (Novocastra,
Newcastle, UK). A well differentiated hepato-carcinoma
was ruled-out and the final diagnosis of hepatic IPT was
made. Our patient received no further treatment. He
remains in good condition one year later.
Discussion
The etiology and pathogenesis of IPTs remain unknown
[4]. Frequently an infectious agent is implicated. In
many reports, the responsible microorganisms found
include Bacteroides caccae, Actinomyces, Klebsiella,
Escherichia coli, Gram-positive cocci and b-hemolytic
Figure 1 CT scan showing a well-encapsulated round tumor,
with low density and low enhancement of the tumor during
the arterial phase.
Figure 2 Macrophages are forming aggregates, while the rest
of the inflammatory cells are interspersed in a stroma with
abundant fibroblasts and collagen bundles. The inflammation
partially extends to the adjacent liver parenchyma. The aggregate of
macrophages is located in the lower right part of the image
(hematoxylin and eosin, × 400).
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the decrease or even resolution of IPTs occurs after
treatment with antibiotics. However, in other reports,
no causative microorganisms have been identified,
which could imply the association of IPTs with hepato-
pancreato-biliary autoimmune diseases, such as IgG4
sclerosing cholangitis [8]. Based on this, many reports
suggest therapeutic management (tumor resolution)
with steroid administration. Differentiating between
IPTs and other focal hepatic lesions remains a major
problem, despite progress in imaging technology. Unfor-
tunately, IPTs may mimic malignant lesions (lymphoma,
malignant fibrous histiocytoma, hepatocellular carci-
noma, metastatic tumor, etc.) and granulomatous lesions
(tuberculosis and sarcoidosis) [4]. The CT-scan usually
reveals lesions with variable contrast enhancement. IPTs
may present with hypovascular character because of
fibrosis and also show a delayed enhancement, similar
to metastatic liver tumors and cholangio-carcinomas [7].
The MRI may produce low signal intensity (hypoin-
tense) on T1-weighted images with moderate to high
signal intensity (hyperintense) on T2 sequence [4,7].
Because MRI provides additional information about
hepatic lesion characteristics, it is often used in our
institute in the metastatic work-up.
In general, it is difficult to distinguish IPTs from
malignant tumors by radiographic studies. Literature
shows that in some (individual) cases a percutaneous
tumor biopsy provided the correct diagnosis. These
patients were treated with antibiotics and/or corticoster-
oids with complete resolution of the lesion; however,
some of these lesions have recurred [9]. In contrast,
there have been numerous studies reported where
hepatic resection was employed, mainly due to the pre-
operative malignant radiographic appearance of the
tumor, and incidentally resected IPTs never recurred
[10].
A further problem suggested in the literature, besides
recurrence, is the potential malignant transformation of
IPTs some years after hepatectomy. It has even been
reported that some patients died of this disease. In par-
ticular, the authors report that these patients developed
non-Hodgkin lymphoma, hepatic sarcoma and recur-
rence of IPTs with multiple hepatic masses and exten-
sion to the thorax some years later [11,12].
Regarding the current case, liver biopsy was not used as
a diagnostic tool due to the strong suspicion of the
lesion’s malignant character, provided by the imaging
findings. While liver biopsy has an undoubted role in the
investigation and management of liver metastases of
unknown origin, it plays a doubtful and probably danger-
ous role in patients with a solitary hepatic mass with high
probability of malignancy [13]. Needle tract seeding has
been reported to occur in 5.1% of patients with hepato-
cellular carcinoma (HCC), who underwent percutaneous
needle biopsy [14]. Hemorrhage, with mortality rates less
than or equal to 1 in 10,000 biopsies in experienced cen-
ters, is another possible, although rare, complication [13].
Furthermore, for the planning of a liver surgical interven-
tion, biopsy of the tumor is not necessary.
Conclusion
A fairly uncommon clinical entity was presented. IPTs
are often difficult to distinguish from hepatic malignant
tumors. The safety of hepatectomy of non-cirrhotic
patients has increased over the past 20 years, with mor-
tality converging to 0%, therefore surgical resection
should be considered as treatment of choice in such
cases [15]. This approach is preferable because it not
only minimizes the risk of a biopsy-related complication
(dissemination in cases of malignancy), but it also
abolishes the possibility of IPT recurrence.
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